Evidence map›Paper›PMID 29657298›Full record

ArticleNon-coding RNA2017

A Novel Long Non-Coding RNA in the hTERT Promoter Region Regulates hTERT Expression.

Sanandan Malhotra, Mallory A Freeberg, Shelby J Winans, James Taylor, Karen L Beemon

Open access · goldAbstract read
In one paragraph

Article in Non-coding RNA, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 40 citations in OpenAlex.

  1. Special Issue "Epigenetic Genes, Biomarkers and Immunotherapy in Cancers".International journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. International journal of molecular sciences · 2024
    Article
  5. Review
  6. Article
  7. Frontiers in immunology · 2022
    Review
  8. Review
  9. Biomedicines · 2021
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Telomere Maintenance in Pediatric Cancer.International journal of molecular sciences · 2019
    Review
  18. Article
  19. PTB-AS, a Novel Natural Antisense Transcript, Promotes Glioma Progression by Improving PTBP1 mRNA Stability with SND1.Molecular therapy : the journal of the American Society of Gene Therapy · 2019
    Article
  20. Diverse regulatory manners of human telomerase reverse transcriptase.Cell communication and signaling : CCS · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sanandan MalhotraDepartment of Biology, Johns Hopkins University, Baltimore, MD 21218, USA. smalhot7@jhu.edu.
Mallory A FreebergDepartment of Biology, Johns Hopkins University, Baltimore, MD 21218, USA. mallory.freeberg@gmail.com.ORCID 0000-0003-2949-3921
Shelby J WinansDepartment of Biology, Johns Hopkins University, Baltimore, MD 21218, USA. swinans1@jhu.edu.
James TaylorDepartment of Biology, Johns Hopkins University, Baltimore, MD 21218, USA. james@taylorlab.org.
Karen L BeemonDepartment of Biology, Johns Hopkins University, Baltimore, MD 21218, USA. KLB@jhu.edu.
Johns Hopkins University · US

Funding

CELLULAR AND MOLECULAR BIOLOGYT32GM007231 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI VAN DOREN, MARK B · 1985 to 2020
$18.4M
NIGMS NIH HHS T32 GM007231
6 · The paper itself

Abstract

A novel antisense transcript was identified in the human telomerase reverse transcriptase (

Indexed as

bidirectional transcriptioncancerlncRNATERT

Identifiers

PMID29657298
PMCPMC5890388
OpenAlexW2781377953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.